Ephla Bio

The submission presents significant red flags that severely undermine its credibility. While the description claims a highly innovative machine learning approach for B-cell targeted therapies with an elite team, the form responses directly contradict professional viability. Claims that 'everyone' is the audience and 'most people have used my product' are blatantly false for a specialized clinical biotech solution. Furthermore, the submitter name 'ThunderFang' and reporting an 'all time marketcap: 2500000' as monthly revenue strongly suggest this is a fabricated submission or a cryptocurrency token masquerading as a biotechnology startup. Due to these unverifiable and contradictory claims, the project receives a negative score in alignment with the calibration guidelines for red flags.